Five-year trends in Malaria prevalence, Plasmodium species distribution, demographic patterns, and seasonal variation at Yejube health center, Baso Liben district, East Gojjam zone, Ethiopia, 2020–2024: Implications for Malaria elimination
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Malaria remains a major global public health problem, with an estimated 282 million cases and 610,000 deaths in 2024, predominantly in the WHO African Region. Ethiopia continues to face substantial malaria transmission and has adopted an elimination strategy emphasizing surveillance, early diagnosis and treatment, and integrated vector control. Assessing local temporal, species-specific, demographic, and seasonal patterns is essential to guide targeted malaria elimination efforts. OBJECTIVE: To assess the five-year temporal trend of malaria prevalence, Plasmodium species distribution, demographic patterns, and seasonal variation among patients attending Yejube Health Center, Baso Liben District, East Gojjam Zone, Ethiopia. METHODS: A facility-based retrospective study was conducted in Yejube Health Center, Baso Liben District, East Gojjam Zone, Ethiopia, using laboratory records from January 2020 to December 2024. All individuals tested for malaria by microscopy during this period were included. Data on test results, Plasmodium species, age, sex, year, and month of diagnosis were extracted from laboratory logbooks. Data were entered in EpiData 4.2, then analyzed using SPSS 24. Descriptive statistics, chi-square tests, and binary logistic regression were used to assess malaria test positivity and associated factors. Adjusted odds ratios (AORs) with 95% confidence intervals (CIs) were calculated, and statistical significance was set at p < 0.05. RESULTS: A total of 7,806 blood films were examined from 2020 to 2024, of which 1,066 were positive for malaria, yielding an overall test positivity rate of 13.65% (95% CI: 12.91-14.44%). Annual positivity declined from 20.08% in 2020 to 4.95% in 2023, followed by a resurgence to 14.66% in 2024. Plasmodium falciparum accounted for 49.6% of confirmed cases, followed by P. vivax (43.3%) and mixed-species infections (7.0%). Although P. falciparum predominated in 2020, P. vivax predominated from 2021 onward. Malaria test positivity was significantly higher among males than females (16.7% vs. 10.1%; p < 0.001) and differed significantly across age groups (p < 0.001). Monthly positivity peaked in October (21.5%) and November (20.3%), with the lowest rate in February (3.9%). In multivariable logistic regression, males had higher odds of malaria positivity than females (adjusted odds ratio [AOR] = 1.79, 95% CI: 1.56-2.06). Compared with individuals aged ≥60 years, the odds were higher among children aged under five years (AOR = 9.27, 95% CI: 1.27-67.77), individuals aged 15-29 years (AOR = 8.39, 95% CI: 1.15-61.27), and those aged 30-59 years (AOR = 9.60, 95% CI: 1.31-70.25). Compared with August, the odds of malaria positivity were significantly higher in September, October, November, and May, but significantly lower in February. CONCLUSION: Malaria test positivity at Yejube Health Center declined from 2020 to 2023 before resurging in 2024. Although P. falciparum predominated overall, P. vivax was the leading species from 2021 onward. Positivity was associated with sex, age, and month of diagnosis, with peaks in October and a secondary increase in May. These findings underscore the need for sustained surveillance and locally tailored malaria control strategies. RECOMMENDATIONS: Strengthen malaria surveillance and seasonal preparedness, particularly before peak-positivity periods. Tailor prevention and health education to males and higher-risk age groups, and improve P. vivax diagnosis, treatment, and relapse prevention. Further studies incorporating population-based, meteorological, and entomological data are recommended to clarify transmission patterns and guide malaria control and elimination efforts.
Source: PLoS ONE
Institution: Debre Markos University
Language: English
Topic: Malaria Research and Control
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,382
OpenAlex ID: W7236696516
